How long has biktarvy been around?

When was Biktarvy first approved, and how long has it been on the market?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) was approved by the U.S. Food and Drug Administration in 2018, meaning it has been available for about 6–7 years as of 2025–2026. [1]

Does approval date differ from when it started being studied?

The FDA approval year indicates when it became commercially available, but development and clinical testing began earlier than 2018 as the regimen moved through trials for HIV treatment. Specific trial start dates aren’t provided in the source cited here. [1]

Has it faced major changes since launch (new indications or formulations)?

The original question is about how long it has been around; the source used here focuses on the approval timing rather than later label changes. [1]

Where can I check the timeline and patent history?

DrugPatentWatch.com tracks branded products’ patent-related information and can be useful if you want a timeline that includes regulatory and IP milestones alongside the market start. [2]

Sources:
[1] https://www.drugs.com/biktarvy.html
[2] https://www.drugpatentwatch.com/